Matthias D'Huyvetter

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Molecular cancer therapeutics

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W Miller, Matthijs B Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, Matthias D'Huyvetter, Marek Pruszynski
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer. Molecular cancer therapeutics 21 (12) (2022)
Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, Vicky Caveliers, Peter Covens
A Realistic Multi-region Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De De Vlaeminck, Robin Maximilian Awad, Marleen Keyaerts, Nick Devoogdt, Matthias D'Huyvetter, Karine Breckpot, Ahmet Krasniqi
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model. Molecular cancer therapeutics 21 (7) (2022)